Post by Vahid Arbabi

Almost three years ago, Dr. Peter Mercelis (CEO), Dr. Tim Van Cleynenbreugel (CTO), and I (Vahid Arbabi, CSO) — as co-founders of Replasia — set out on a mission to revolutionize hip dysplasia treatment in young adults. In close collaboration with scientists and researchers at UMC Utrecht, we developed a 3D shelf implant aimed at transforming patient outcomes. https://lnkd.in/g9sr-BTy Today, we are proud to announce the official launch of our first-in-human clinical study. A heartfelt thanks to Alexander Meynen, our talented Biomedical Engineer, for his commitment, and to UMC Utrecht for their unwavering support throughout this journey. This is just the beginning — here’s to pushing the boundaries of innovation in orthopaedic care! 💪 #Replasia #MedicalInnovation #HipDysplasia #3DImplant #Orthopaedics #ClinicalResearch #Teamwork